Corrigendum to “Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway” [Int. Immunopharmacol. 128 (2024) https://doi.org/10.1016/j.intimp.2023.111466]
-
Published:2024-04
Issue:
Volume:131
Page:111873
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Geng Hongyu,Zhang Hongbo,Cheng Lianfang,Dong Shimin